分类： health

Uganda has reached a critical milestone in its fight against the ongoing regional Ebola outbreak, with the country’s last confirmed active patient discharged from treatment facilities. No confirmed active infections remain across the nation, officials confirmed, triggering a 42-day mandatory waiting period that will end with an official declaration of Ebola-free status if no new cases are documented.

The outbreak in Uganda traces back to early May, when health authorities confirmed the first case of the Bundibugyo Ebola strain in a patient who crossed into the country from the neighboring Democratic Republic of Congo (DRC) to seek medical care. The DRC has been the epicenter of the current regional outbreak. Over the course of the response, Uganda recorded a total of 20 confirmed cases, the vast majority of which were travelers crossing from the DRC, with just two fatalities reported.

In contrast, the Ebola outbreak in the DRC has grown far more severe: official government data from the central African nation shows more than 2,000 confirmed infections and 796 deaths to date. Experts warn the actual caseload is likely far higher, with a World Health Organization official noting earlier this week that the true number of infections could be four times the official recorded figure. The virus is also believed to have circulated undetected in DRC communities for months before the outbreak was formally declared just two months ago, leaving authorities playing catch-up in their response.

Speaking after the discharge of Uganda’s final patient, Health Minister Dr. Chris Baryomunsi called the milestone a momentous occasion. “It demonstrates that with early detection, prompt treatment and a strong health system, Ebola can be defeated,” he said. Despite the positive development, Uganda’s Ministry of Health has urged the public to maintain caution and remain vigilant against a potential resurgence of the virus. In a public statement posted to X, the ministry advised, “If you develop symptoms such as fever, vomiting, diarrhoea or unexplained bleeding, seek immediate medical care.”

Uganda has built up robust response protocols over the past two decades, having weathered multiple Ebola outbreaks during that period. Current measures include immediate isolation of suspected cases, comprehensive contact tracing to stop chains of transmission, and widespread public outreach to educate communities on symptom recognition and prevention. From the earliest days of the current outbreak, Uganda activated tightened entry screening and other public health protocols to limit the spread of the virus from the DRC, a strategy that public health experts say has contributed to its successful containment so far.

As Uganda celebrates its progress, the DRC continues to struggle to bring the outbreak under control. The escalating crisis has prompted new travel restrictions from the United States, which recently announced that all U.S. citizens returning home after visiting the DRC must complete a 21-day quarantine in a third country before being allowed entry into the U.S. Previously, travelers from the DRC were able to enter the U.S. through designated airports after passing through routine health screening.

This new policy has drawn concern from international aid groups. Franklin Graham, CEO of an organization that operates multiple Ebola treatment centers in the region, told Reuters the restriction could discourage U.S. medical workers from volunteering to respond to the outbreak in affected areas, worsening the already strained public health response.

Ebola is a viral illness that targets the body’s immune system and organs. The virus is naturally hosted by wild animals, most commonly fruit bats, and zoonotic spillovers to humans typically occur when people handle infected animal carcasses. Once established in human populations, the virus spreads exclusively through direct contact with infected bodily fluids such as blood.

Two months after an Ebola outbreak emerged in eastern Democratic Republic of the Congo, the United Nations has issued a stark warning that the epidemic is spreading far more rapidly than official tracking has captured, with its true scale potentially reaching two to four times the size of published case counts.

As of July 11, official data logged nearly 2,000 confirmed infections and more than 700 deaths across five affected provinces, already ranking this event as the third-largest recorded Ebola epidemic in history and the fastest-growing outbreak the global health community has faced in modern history. Chikwe Ihekweazu, executive director of the WHO Health Emergencies Programme, confirmed the alarming acceleration following a visit to the outbreak’s epicenter in Bunia, Ituri Province, telling reporters in Geneva that the past month has seen the sharpest single-month case growth of any Ebola outbreak the WHO has ever responded to.

In recent days, Ihekweazu noted, the outbreak has hit some of its highest single-day infection peaks, with more than 80 new confirmed cases recorded in a single 24-hour window. The most worrying trend, health officials emphasize, is that a large share of new fatalities are occurring in community settings, with patients dying before they can reach formal treatment facilities. Caused by the Bundibugyo Ebola strain – for which no approved vaccines or targeted treatments currently exist – the outbreak has already spread beyond its original Ituri Province epicenter to neighboring Haut-Uele and Tshopo provinces. While roughly 95 percent of cases remain concentrated in Ituri, hidden, untraced transmission chains are driving the epidemic’s expansion.

WHO epidemiological modeling estimates that the true caseload is vastly undercounted. “You have to imagine that this is a fire. There’s something driving the fire in its heart, and it’s also expanding at the same time,” Ihekweazu said. Even with improvements to diagnostic testing and disease surveillance, roughly 80 percent of new confirmed cases are not linked to already known contact chains, confirming that large portions of transmission remain undetected by response teams.

The outbreak has also taken a heavy toll on the frontline workforce: the Africa Centres for Disease Control and Prevention (Africa CDC) has confirmed at least 112 infections and 35 deaths among healthcare workers responding to the crisis. For aid organizations operating on the ground, rapidly shifting outbreak dynamics have made containment efforts far more challenging. Frederick Lai Manantsoa, emergency coordinator for Doctors Without Borders in DR Congo, explained that persistent insecurity, large-scale population movement and internal displacement have made routine surveillance and contact tracing increasingly difficult. “The success of the response depends on how quickly we can identify suspected cases, isolate them and cut the chain of transmission,” Manantsoa said. “There are several dynamics of the outbreak which make surveillance and contact tracing extremely complex.”

Despite the grim outlook, global and local health authorities have recorded important progress toward addressing the outbreak. This week marked the launch of new clinical trials focused on developing effective treatments and preventive interventions for the Bundibugyo strain, marking a new phase in the global response. The EBO-PEP platform trial, based in Ituri Province, aims to recruit nearly 1,000 high-risk contacts across DR Congo and neighboring Uganda to test whether antiviral medications can prevent infection after exposure to the virus.

Africa CDC has pledged $1 million to support the trial, while the governments of DR Congo and South Africa have committed an additional $5 million in combined funding. WHO Director-General Tedros Adhanom Ghebreyesus called the trial a potential turning point for Ebola response, noting that the research could create a “game-changing approach” for preventing infection among exposed people and improve global capacity to bring future outbreaks under control quickly.

In the conflict-wracked eastern region of the Democratic Republic of the Congo, a devastating Ebola outbreak driven by the rare Bundibugyo virus has reached a grim milestone, with confirmed cases climbing to 2,011 and total deaths hitting 754, according to newly released official government data. World Health Organization (WHO) officials confirm this is the fastest-expanding Ebola event ever recorded, outpacing containment efforts at every turn.

The crisis has been compounded by growing unrest among frontline medical teams, who have walked off the job over unmet pay promises. On Wednesday, staff at Bunia General Hospital — the largest medical facility in the outbreak’s epicenter — launched a strike, barricading the hospital entrance to demand long-delayed wages earned while working in high-risk, resource-strapped conditions. This industrial action follows a similar strike just two days earlier at an Ebola treatment center in Rwampara, another Ituri Province hotspot that has borne the brunt of the outbreak. That strike ended after workers secured a government commitment to issue back pay within 72 hours, but many frontline staff report they have not received any compensation since the outbreak began in mid-May, leaving deep lingering frustration.

Public health experts warn multiple overlapping barriers are making the outbreak extremely difficult to contain. The most pressing issue is the unprecedented rate of spread: roughly 80% of all new confirmed cases stem from unknown transmission chains that officials have been unable to map. To date, authorities have only successfully traced 67% of known close contacts of infected patients, a rate far too low to halt transmission. Complicating tracing efforts further, health teams have still not identified the outbreak’s index case (patient zero), while widespread population displacement from ongoing armed conflict and frequent cross-community movement of artisanal miners have scattered thousands of potentially exposed people across the region.

Unlike previous Ebola outbreaks in Congo that were caused by the more common Zaire strain — for which effective, approved vaccines and treatments already exist — there are no licensed medical countermeasures for the Bundibugyo virus driving this current event. In a small glimmer of hope for the response, enrollment for a clinical trial testing two promising investigational treatments has recently launched in Ituri, though results will not be available for months.
Additional systemic challenges continue to undermine response work: a critical funding gap has left operations under-resourced, repeated attacks on health facilities have forced care closures in high-risk areas, ongoing armed violence in eastern Congo prevents teams from reaching remote communities, and deep-seated mistrust between local populations and public health workers has reduced cooperation with contact tracing and isolation efforts.
As of the latest data release, 753 patients remain in isolation care at hospitals across the region, while 366 people have recovered from infection so far. More than 100 frontline healthcare workers have already contracted the virus since the outbreak began, according to WHO figures. WHO’s emergencies chief Dr. Chikwe Ihekweazu, who recently completed an assessment visit to Bunia, noted that many of the newly recorded deaths are people who never accessed care, dying in their home communities before medical teams could intervene.

In the sweltering hills of central Cameroon, Mabel Djoumessi trekked for miles along rain-soaked, mud-caked dirt roads, her 9-month-old son Kenfack strapped securely to her back. Her destination: a local clinic, where Kenfack was scheduled for his malaria vaccine — an appointment too urgent to skip, even in poor conditions.

For generations, malaria has reigned as one of the deadliest threats to young children across the African continent, leaving millions of families grappling with repeated sickness and unmanageable medical costs. Today, Kenfack has never contracted the disease, a outcome his mother credits directly to the new malaria vaccine that has entered routine childhood immunization schedules across the country. “My other children, who never had access to the vaccine, get sick all the time,” Djoumessi explained, as she sat alongside other mothers holding their infants at Soa District Hospital.

It has now been more than two years since Cameroon made history as the first nation to integrate the RTS,S malaria vaccine into its standard routine immunization program, and frontline health workers are already documenting clear public health gains: severe malaria cases among children have dropped noticeably, and pediatric hospital wards that once overflowed with sick young patients are now far emptier. But a critical gap threatens to undermine these hard-won gains: too few families are returning for the fourth and final booster dose that the World Health Organization (WHO) confirms is essential to sustaining long-term immunity against the parasite.

This low fourth-dose coverage is not an isolated challenge limited to Cameroon. It reflects a systemic issue that plagues multidose vaccine rollouts across the entire African continent, where barriers ranging from travel costs to competing work and childcare responsibilities keep families from returning for follow-up doses months after the initial rounds of vaccination.

Global public health data underscores just how high the stakes are: the WHO and UNICEF estimate that malaria kills one child under the age of five every single minute worldwide, with more than 90% of those deaths occurring in Africa. Cameroon alone is among 11 nations that bear roughly 70% of the world’s total malaria burden; the country recorded an estimated 7.6 million cases and 11,700 deaths from the disease in 2024. Early 2025 data from Cameroon’s National Malaria Control Program shows a 33,000-drop in cases compared to the previous year, though experts caution that the vaccine is not the sole driver of this decline.

“Isolating the specific impact of malaria interventions requires advanced statistical modeling, and we do not yet have a framework to quantify the vaccine’s exclusive contribution,” explained Dr. Bomba Amougou, head of prevention at the National Malaria Control Program. “It is accurate to say the vaccine has contributed to falling cases and deaths, but it is not the only cause.”

The WHO first endorsed broad use of the RTS,S vaccine in 2021, after multi-year pilot programs in Ghana, Kenya and Malawi found the shot cut child mortality from malaria by 13% among eligible children. Separate clinical trials across several African nations found that both RTS,S and the newer R21 vaccine reduced clinical malaria cases by more than 50% in the first year after three doses. To date, more than 52 million doses have been delivered to 25 high-risk African nations, supported by Gavi, the Vaccine Alliance. But the rollout faces major funding constraints following sweeping cuts to foreign aid from the Trump administration and other donors. Currently, Gavi is only able to guarantee vaccine supplies to cover up to 70% of eligible children in the world’s lowest-income countries.

In Cameroon, coverage for the first three doses of the vaccine — given at six, seven, and nine months of age — has slowly improved since the program launched, climbing from 66% to 68% for first doses, 53% to 58% for second doses, and 48% to 59% for third doses between 2024 and 2025, according to Amougou. But coverage for the fourth dose, scheduled when a child turns two years old, remains stuck at just 25% as of 2025.

Amougou noted that gaps stem from both parent and provider awareness issues: “Parents and even some health workers sometimes forget the fourth dose, particularly because it is administered more than a year after the third, and this is still a relatively new vaccine.” Receiving all four doses is critical, he emphasized: “Getting every shot makes the protection far more potent, and vaccination must work alongside other tools like bed nets, early treatment, and improved sanitation to beat malaria.”

Data from the earlier pilot programs across Ghana, Kenya and Malawi confirms that the low fourth-dose coverage problem is widespread. While 80% of eligible children received their first dose in those countries, coverage dropped to just 46% for the fourth dose, according to a 2024 study published in the peer-reviewed Malaria Journal. Researchers found that high parent acceptance of the vaccine itself — driven by widespread familiarity with malaria’s deadly toll — but barriers like transport costs, lack of appointment reminders, poor care follow-up, and competing work and family obligations keep families from returning for the final booster months later.

Gavi Chief Executive Officer Dr. Sania Nishtar emphasized that low late-dose coverage is an early, solvable challenge that should not overshadow the vaccine’s life-saving value. Nishtar noted that malaria vaccine actually has the lowest rate of parental hesitancy of any routine vaccine, a reflection of how desperate communities are for tools to protect their children from a preventable killer. “There is huge demand from governments and communities for this vaccine,” she said.

In response to the coverage gap, Cameroon and other affected African nations have launched national “Big Catch-up” campaigns to remind parents and health workers to prioritize the fourth dose and bring eligible children who have missed their booster in for vaccination. Looking ahead, global health researchers are actively developing a single-dose malaria vaccine, which would eliminate the need for multiple follow-up visits and dramatically improve coverage. “The fewer the doses of a vaccine to be administered, the higher the uptake and the easier the administration,” Nishtar explained.

For many low-income families across Cameroon, preventing malaria is not just a matter of child health — it is also a matter of financial survival. Georgette Caroline Mengbwa, a mother of three waiting for her youngest daughter’s third dose at Soa District Hospital, explained that her two older children were born before the vaccine was available, and face repeated bouts of sickness that drain the family’s limited income. “They fall ill every two or three months, and I have to spend between $53 and $107 every time one or all of them get sick,” she said. “It’s a lot of money.” Those costs are devastating in a country where the official monthly minimum wage is just $76, and nearly 40% of the population lives below the poverty line.

For mothers like Djoumessi, the vaccine is already a life-changing tool, and she says she has every intention of returning for Kenfack’s fourth dose when he turns two. “I don’t want him to suffer like the others,” she said.